Aarey Drugs and Pharmaceuticals Ltd Q1 FY2024 PAT at Rs. 72.47 lakhs

AAREY DRUGS & PHARMACEUTICALS LTD. has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 51.6534 crores during the period ended June 30, 2023 as compared to Rs. 163.7211 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 0.7247 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 0.3629 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 0.29 for the period ended June 30, 2023 as compared to Rs. 0.14 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 51.6534 crs	₹163.7211 crs	-68.45%
Net Profit	₹0.7247 crs	₹0.3629 crs	99.70%
EPS	₹0.29	₹0.14	107.14%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 51.6534 crores during the period ended June 30, 2023 as compared to Rs.119.6951 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.0.7247 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.0.8001 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.0.29 for the period ended June 30, 2023 as compared to Rs.0.32 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 51.6534 crs	₹119.6951 crs	-56.85%
Net Profit	₹0.7247 crs	₹0.8001 crs	-9.42%
EPS	₹0.29	₹0.32	-9.38%

Shares of AAREY DRUGS & PHARMACEUTICALS LTD. was last trading in BSE at Rs. 51.69 as compared to the previous close of Rs. 48.94. The total number of shares traded during the day was 123275 in over 1274 trades.

The stock hit an intraday high of Rs. 53.49 and intraday low of 49.50. The net turnover during the day was Rs. 6389046.00.

Source : Equity Bulls

Keywords

AareyDrugsandPharmaceuticals Q1FY24 ResultUpdate